Worth a Buy Yet? Haven't held hexo since the Hydropothecary days a few years ago. Redecan revenue puts HEXO up with Canopy and Tilray in terms of revenue, at a fraction of the market cap of the bigger players. My biggest concern is that Sebastian has more tricks up his sleeve to absolutely burn shareholders more so than he's already done - specifically the endless raises and dilution.
I'm conflicted, seems undervalued but I also think the folks at the helm are clueless here. Thoughts?